Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ

Key Points

• Drug resistance in pancreatic cancer cells is linked to the downregulation of microrna-455-3p, impacting viability.
• Key evidence indicates that lower levels of microrna-455-3p correlate with increased cancer cell proliferation.
• The approach involves targeting the protein TAZ, demonstrating its role in the proliferation dynamics of pancreatic cancer cells.
• This highlights potential therapeutic targets for overcoming drug resistance in pancreatic cancer.